[1]
T. Kawashiri, “Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS)”, J Pharm Pharm Sci, vol. 24, pp. 499–508, Oct. 2021.